Recent studies investigated the complicated interplay between MAPK and AMPK signaling in cellular carcinogenesis and their implications in cancer therapies, revealing that AMPK signaling can reversibly regulate hyperactive MAPK signaling in cancer cells by phosphorylating its key components, RAF/KSR (kinase suppressor of Ras) family kinases [65]. Here, KSR1 is linked to cancer.